echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Upstream and Downstream products of 7-bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine

    The Upstream and Downstream products of 7-bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine

    • Last Update: 2023-05-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    7-Bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine is a chemical compound that is commonly used in the pharmaceutical industry as an intermediate for the synthesis of various medications.
    It is also used in research and development for the discovery of new drugs and treatments.
    The compound can be synthesized through several different methods, each with its own unique set of advantages and challenges.


    One of the most common methods for the synthesis of 7-bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine involves a two-step process that involves the bromination of 7-chloro-4-oxo-5H-pyrrolo[3,2-d]pyrimidine followed by the coupling of the resulting bromide with chloroformic acid.
    This process is effective and yield is good, but it requires the use of toxic and flammable reagents such as bromine gas and chloroformic acid.


    Another method for the synthesis of 7-bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine involves the use of a brominating agent, such as tetrabromoethane, in the presence of a base, such as potassium carbonate.
    This method is less hazardous than the previous one, since it does not require the use of bromine gas or chloroformic acid, but it may have lower yield.


    Downstream Products
    7-bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine is an important building block for the synthesis of several pharmaceuticals, including the antibiotic clarithromycin and the anti-inflammatory drug celecoxib.
    It is also used in the synthesis of other compounds such as SARS-CoV-2 antiviral drugs.


    Upstream Products
    The precursor of 7-bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine is 7-chloro-4-oxo-5H-pyrrolo[3,2-d]pyrimidine, which is commonly synthesized from chloroacetamide and benzaldehyde via a sequence of chemical reactions.
    The intermediate is then brominated to give 7-bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine.


    In addition to its use as an intermediate in pharmaceutical synthesis, 7-bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine has also been investigated for its own potential therapeutic effects.
    Research has shown that it has anticancer, anti-inflammatory, and antiviral properties.


    Conclusion
    7-bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine is an important compound in the pharmaceutical industry, serving as an intermediate for the synthesis of several important drugs.
    The compound can be synthesized through several different methods, each with its own advantages and challenges.
    The downstream products of the compound are also important in the pharmaceutical industry.
    The compound also has potential therapeutic effects, and further research is being done to explore its full potential.
    It is important to note that the production and use of this compound should be done in a safe and responsible manner, taking into consideration the potential health and environmental risks associated with its production and use.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.